| Arwinnah Bautista, MD | |
|
1430 E Plaza Blvd Ste E19a, National City, CA 91950-3690 | |
| (619) 434-2813 | |
| (855) 631-3720 |
| Full Name | Arwinnah Bautista |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 1430 E Plaza Blvd Ste E19a, National City, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073579173 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | C51221 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Paradise Valley Hospital | National city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paradise Valley Medical Group Inc | 2365538709 | 8 |
| Arwinnah Bautista Md Pc | 6709023245 | 2 |
News Archive
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.
The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.
A new study indicates that patients aged 75 years or older who have confined kidney tumors do not live longer if they have their entire kidney removed. The research reveals that these patients typically have other medical problems of greater significance and that many should receive more conservative cancer-related care, such as observation or treatments that spare the noncancerous parts of their kidneys. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 4 days ago
| Entity Name | Paradise Valley Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003037722 PECOS PAC ID: 2365538709 Enrollment ID: O20071017000572 |
News Archive
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.
The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.
A new study indicates that patients aged 75 years or older who have confined kidney tumors do not live longer if they have their entire kidney removed. The research reveals that these patients typically have other medical problems of greater significance and that many should receive more conservative cancer-related care, such as observation or treatments that spare the noncancerous parts of their kidneys. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 4 days ago
| Entity Name | Arwinnah Bautista Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053501213 PECOS PAC ID: 6709023245 Enrollment ID: O20130501000069 |
News Archive
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.
The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.
A new study indicates that patients aged 75 years or older who have confined kidney tumors do not live longer if they have their entire kidney removed. The research reveals that these patients typically have other medical problems of greater significance and that many should receive more conservative cancer-related care, such as observation or treatments that spare the noncancerous parts of their kidneys. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arwinnah Bautista, MD Po Box 390232, San Diego, CA 92149-0232 Ph: (619) 267-0553 | Arwinnah Bautista, MD 1430 E Plaza Blvd Ste E19a, National City, CA 91950-3690 Ph: (619) 434-2813 |
News Archive
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.
The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.
A new study indicates that patients aged 75 years or older who have confined kidney tumors do not live longer if they have their entire kidney removed. The research reveals that these patients typically have other medical problems of greater significance and that many should receive more conservative cancer-related care, such as observation or treatments that spare the noncancerous parts of their kidneys. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 4 days ago
Dr. Dottie Ann Sazon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 655 Euclid Ave, Suite #206, National City, CA 91950 Phone: 619-267-3188 Fax: 619-267-3388 | |
Dr. Ira Richard Braverman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 Euclid Avenue, Suite 201, National City, CA 91950 Phone: 619-267-8181 Fax: 619-479-6750 | |
Andrew J Alongi, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2345 E 8th St, Suite 101, National City, CA 91950 Phone: 619-779-7905 Fax: 619-779-7906 | |
Dr. Troy Huvilla Niguidula, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 610 Euclid Avenue, Suite 201, National City, CA 91950 Phone: 619-267-8181 Fax: 619-479-6750 | |
Dr. Man Hung Jasmine Chow, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 655 Euclid Ave, 210, National City, CA 91950 Phone: 619-475-4004 Fax: 619-470-2793 | |
Dr. Valerie Cynthia Altavas, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 655 Euclid Ave, Suite 302 304, National City, CA 91950 Phone: 619-472-4575 Fax: 619-472-4530 |